We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LLC:ASXLendlease Group Analysis

Data as of 2026-09-06 - not real-time

A$2.89

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Lendlease Group is priced at AUD 2.89 and its moving averages line up in bearish order, the shorter trailing the longer. The last 30 days have gained 2.8%. Momentum indicators put RSI at 46.6 (neutral) with MACD reading bullish. Price has been bracketed by support at AUD 2.72 and resistance at AUD 3.30.
Valuation screens as undervalued: a P/E of 11.7 sits below the sector average of 31.3. Analyst price targets sit 24.3% above the current price. Revenue is contracting at 19.6% on a -13.8% profit margin. The 5.45% dividend yield looks covered by current payout levels.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 45.9%, a beta of 0.25 and a maximum drawdown of 57.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.

Top Market Events

What’s happening with A2 Milk Co Ltd ASX: A2M , Lendlease Group ASX: LLC , and JB Hi Fi Ltd ASX: JBH shares on Monday?ASX investors punished Lendlease, Megaport and JB Hi-Fi this week.Detailed price information for Lendlease Corporation Limited LLESF from The Globe and Mail including charting and...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 3.72
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 11.7 versus sector average of 31.3
  • Trading below the 200-day average of 3.72

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 11.7 versus sector average of 31.3
  • Negative profit margin of -13.8%
  • Analyst targets imply +24.3% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth-19.60%
Profit Margin-13.80%
P/E Ratio11.7
ROE-14.99%
ROA0.06%
Debt/Equity96.62
P/B Ratio0.5
Op. Cash FlowA$-1356999936
Free Cash FlowA$-1960000000
Industry P/E31.3

Technical Analysis

TrendBearish
RSI46.6
SupportA$2.72
ResistanceA$3.30
MA 20A$2.94
MA 50A$2.99
MA 200A$3.72
MACDBullish
VolumeStable
Fear & Greed Index95.48

Valuation

Target PriceA$3.59
Upside/Downside24.32%
GradeUndervalued
TypeValue
Dividend Yield5.45%

Risk Assessment

Beta0.25
Volatility45.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.